Her discoveries are the hope of thousands of people
In the gilded halls of Santander's Palacio de Festivales, Spanish immunologist Carola García de Vinuesa received the inaugural Marqués de Valdecilla National Medicine Prize — a €50,000 honor born from a hospital centenary and designed to become a national benchmark for scientific excellence. Her decades of immunological research, credited with offering hope to thousands of patients worldwide, were recognized not merely as professional achievement but as an act of service to human life itself. The ceremony arrived at a moment when the very foundations of immunological science face public skepticism, lending the occasion the quiet urgency of a discipline defending its own legacy.
- Immunology's foundational principles are under pressure, and García de Vinuesa used her acceptance platform to mount a public defense of her field's scientific integrity.
- The prize — Spain's first of its kind — carries the weight of a national statement, signaling that medical research is not peripheral but central to regional and cultural identity.
- Vaccines anchored her remarks with a striking moral clarity: 150 million lives saved in fifty years, most of them children, a figure that transforms abstract science into undeniable human consequence.
- Cantabria's regional government leveraged the ceremony to project a broader vision of medical excellence, invoking organ donation leadership, a Digital Health Law, and a forthcoming Health Innovation Park.
- Nearly two hundred attendees, a symphony orchestra, and civil and military authorities transformed what might have been an academic honor into something closer to a civic declaration.
On a Thursday afternoon in Santander, Carola García de Vinuesa stood in the Sala Pereda of the Palacio de Festivales to accept the inaugural Marqués de Valdecilla National Medicine Prize — an award created in anticipation of the hospital's centenary in 2029. Cantabria's regional president, María José Sáenz de Buruaga, presented the €50,000 prize and spoke plainly about the stakes of García de Vinuesa's work: her discoveries, Buruaga said, are the hope of thousands.
The formal citation, read by regional health minister César Pascual, described García de Vinuesa as embodying "the best of science and humanity" — a researcher whose career demonstrates the force of vocation and the beauty of placing knowledge in service of life. The prize is designed to become a reference point for Spanish medicine, honoring scientific excellence, social commitment, and international leadership in equal measure.
García de Vinuesa received the honor not as personal recognition but as a celebration of medicine itself. She spoke with urgency about immunology's foundational principles facing contemporary threats, and anchored her remarks in a single, clarifying statistic: vaccines have saved more than one hundred fifty million lives in the last fifty years, the majority of them children under five. The figure was not rhetorical flourish — it was a defense.
Buruaga used the occasion to affirm Cantabria's broader medical ambitions, describing the Valdecilla name as the spearhead of an entire ecosystem of excellence and pointing toward a Digital Health Law and a Health Innovation Park on the horizon. The Orquesta Sinfónica del Cantábrico performed, and civil and military authorities filled the room — transforming a scientific prize into something that felt, unmistakably, like a regional act of faith in the future of medicine.
Carola García de Vinuesa stood in the Sala Pereda at the Palacio de Festivales in Santander on Thursday afternoon, receiving the inaugural Marqués de Valdecilla National Medicine Prize—a new award created to mark what will be the centenary of the Hospital Universitario Marqués de Valdecilla in 2029. The Spanish immunologist, recognized as one of the world's most prominent researchers in her field, accepted the honor with what she described as gratitude and a profound sense of responsibility. María José Sáenz de Buruaga, president of Cantabria, presented the prize and spoke directly to the weight of García de Vinuesa's work: her discoveries, Buruaga said, are the hope of thousands of people.
The ceremony drew nearly two hundred attendees and carried the formal weight of a state occasion. César Pascual, the regional health minister, read the formal citation, describing García de Vinuesa as embodying "the best of science and humanity"—someone whose work demonstrates the force of vocation, the courage of perseverance, and the beauty of placing knowledge in service of life. The prize itself carries fifty thousand euros and is designed to become a reference point for Spanish medicine, recognizing scientific excellence, social commitment, and international leadership.
In her remarks, García de Vinuesa framed the award not as personal recognition but as a celebration of medicine and science itself, and as evidence that society values knowledge, creativity, rigor, and the sacrifice that research and patient care demand. She spoke with particular urgency about immunology, her field of expertise, noting that its foundational principles face threats in the current moment. The Hospital Universitario Marqués de Valdecilla, she said, has changed the history of medicine itself.
Vaccines became a focal point of her remarks. She called them one of the greatest achievements in public health and cited a stark figure: in the last fifty years, vaccines have saved more than one hundred fifty million lives, the majority of them children under five years old. This statistic anchored her defense of immunological science—not as abstract research but as a discipline with direct, measurable impact on human survival.
Buruaga used the occasion to highlight García de Vinuesa's international standing, describing her as among the world's most distinguished immunologists and noting that her work is generating significant expectations while inspiring researchers and physicians globally. The president also seized the moment to affirm the Cantabrian health system more broadly, calling the Valdecilla brand "the spearhead of an entire ecosystem of excellence." She pointed to the region's leadership in organ donation and transplantation, and looked forward to new initiatives including a Digital Health Law and a Health Innovation Park.
The event included a musical performance by the Orquesta Sinfónica del Cantábrico and was attended by various civil and military authorities, including the president of the regional parliament and the government's delegate. The ceremony itself became a statement about how Spain's regional government sees medical research—not as a specialized pursuit but as central to the region's identity and future. For García de Vinuesa, the prize appears to have landed at a moment when she felt compelled to defend her discipline publicly, suggesting that immunology, despite its proven track record, faces skepticism or pressure that requires active advocacy.
Citas Notables
Her discoveries are the hope of thousands of people— María José Sáenz de Buruaga, president of Cantabria
A celebration of medicine and science, and a reflection that we value knowledge, creativity, rigor, and the sacrifice that research and patient care require— Carola García de Vinuesa, in her acceptance remarks
La Conversación del Hearth Otra perspectiva de la historia
Why does a prize for medical research matter enough to draw two hundred people and regional officials to a formal ceremony?
Because it signals what a society actually values. This isn't just honoring one person—it's a statement that immunology, vaccines, and the slow work of understanding how the body defends itself are worth defending right now.
García de Vinuesa seemed to feel that immunology itself was under threat. What did she mean by that?
The source material suggests the "foundations of knowledge, especially in immunology, are being threatened." She didn't elaborate, but the context matters—there's been global skepticism about vaccines and public health science. She was using this platform to push back.
The figure about vaccines saving one hundred fifty million lives in fifty years—why lead with children under five?
Because it's the most undeniable measure of impact. You can argue about policy or funding or methodology, but you can't argue with a child who lived because of a vaccine. That's the ground she chose to stand on.
This is the first prize of its kind in Spain. Why create it now, ahead of the hospital's centenary in 2029?
It's a way of saying: we're thinking about what matters for the next hundred years. By honoring García de Vinuesa now, they're saying immunology and medical research are foundational to that future.
What does it tell us that she accepted the prize by reframing it as a celebration of medicine and science, not herself?
It tells us she understands the real audience isn't the room—it's everyone who doubts whether this work matters. She was speaking to that doubt.